Overview
NEPH market data
Price History
NEPH price chart
Valuation & Profitability
- P/E (TTM)
- 64.38 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.11 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.68 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 4.1% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $2.66 – $6.42 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $50M · P/B 5.08 · P/S 2.61.
Company News
Nephros shares are trading higher after the company reported better-than-expected Q2 financial results.Benzinga · Aug 7, 2026, 12:52 PM
12 Industrials Stocks Moving In Thursday's After-Market SessionBenzinga · Aug 6, 2026, 9:06 PM
Nephros Q2 EPS $0.11 Beats $0.00 Estimate, Sales $6.017M Beat $4.994M EstimateBenzinga · Aug 6, 2026, 8:04 PM
Nephros to Participate in the “Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ETGlobenewswire Inc · Jul 20, 2026, 12:02 PM
Nephros Added To Russell Microcap Index At Conclusion Of 2026 Annual ReconstitutionBenzinga · Jul 6, 2026, 11:05 AM
Nephros to Host Virtual Investor Event: “Beyond Filtration: The Nephros Model in Action”Globenewswire Inc · Jun 18, 2026, 11:15 AM
Nephros Positions Ultrafiltration Technology as a Solution to Emerging Microplastic Risk in WaterGlobenewswire Inc · Jun 16, 2026, 11:15 AM
8-K filing — NEPHROS INC (NEPH)SEC EDGAR · Jun 12, 2026, 9:43 PM